(Reuters) - U.S. health regulators on Monday approved an Eli Lilly and Co drug to treat advanced stomach cancer and a form of cancer in the area where the esophagus joins the stomach. The Food and Drug Administration said it has approved ramucirumab for use in patients whose cancer cannot be surgically removed or has spread following chemotherapy treatment. It will be sold by Lilly under the brand name Cyramza. The drug, which works by blocking blood supplies that tumors need to grow, had been considered one of the most important in Lilly's developmental pipeline. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment